Your Dynamic Duo: Sugammadex & Quantitative TOF Monitor

Join us for an in-depth webinar that challenges the overreliance on sugammadex alone and spotlights the indispensable role of quantitative train-of-four (TOF) monitoring in optimizing patient care.

Your details

I agree that Senzime will process my data to communicate with me about this webinar and other similar events. For a complete understanding of how we process data, please read our Privacy Policy.

Subscribing to

Confirm sign-up

Key Learning Objectives

How quantitative train-of-four monitoring can help tailor sugammadex dosing to individual patient needs.
Evidence indicating that a majority of patients receive an improper dose—some too much, others too little.
The potential adverse events associated with sugammadex use and strategies to mitigate these risks.
Best practices and real-world applications from both U.K. and U.S. experts to optimize patient safety.

Moderator
Michael Noble
VP, Global Marketing, Senzime

Presenters
Dr. Ross Renew (U.S)
Dr. Grant Rodney (U.K.)

Share this webinar